156 related articles for article (PubMed ID: 8739775)
1. Molecular biology of heart disease. Synopsis of the pathophysiological basis of cardiac hypertrophy, familial hypertrophic cardiomyopathy, long QT syndrome and Marfan syndrome.
Kurabayashi M; Yazaki Y
Intern Med; 1996 Apr; 35(4):243-8. PubMed ID: 8739775
[TBL] [Abstract][Full Text] [Related]
2. [Molecular genetics of cardiovascular diseases].
Schunkert H; Hense HW
Dtsch Med Wochenschr; 1995 Apr; 120(15):533-9. PubMed ID: 7720536
[No Abstract] [Full Text] [Related]
3. The phenotype/genotype relation and the current status of genetic screening in hypertrophic cardiomyopathy, Marfan syndrome, and the long QT syndrome.
Burn J; Camm J; Davies MJ; Peltonen L; Schwartz PJ; Watkins H
Heart; 1997 Aug; 78(2):110-6. PubMed ID: 9326982
[No Abstract] [Full Text] [Related]
4. Impact of laboratory molecular diagnosis on contemporary diagnostic criteria for genetically transmitted cardiovascular diseases:hypertrophic cardiomyopathy, long-QT syndrome, and Marfan syndrome. A statement for healthcare professionals from the Councils on Clinical Cardiology, Cardiovascular Disease in the Young, and Basic Science, American Heart Association.
Maron BJ; Moller JH; Seidman CE; Vincent GM; Dietz HC; Moss AJ; Sondheimer HM; Pyeritz RE; McGee G; Epstein AE
Circulation; 1998 Oct; 98(14):1460-71. PubMed ID: 9841131
[No Abstract] [Full Text] [Related]
5. Role of DNA testing for diagnosis, management, and genetic screening in long QT syndrome, hypertrophic cardiomyopathy, and Marfan syndrome.
Vincent GM
Heart; 2001 Jul; 86(1):12-4. PubMed ID: 11410552
[No Abstract] [Full Text] [Related]
6. Genetic testing for risk stratification in hypertrophic cardiomyopathy and long QT syndrome: fact or fiction?
Ackerman MJ
Curr Opin Cardiol; 2005 May; 20(3):175-81. PubMed ID: 15861004
[TBL] [Abstract][Full Text] [Related]
7. [Genetics of hereditary cardiopathies].
Debrus S; de Meeus A; Jean MK; Bouvagnet P
Arch Mal Coeur Vaiss; 1996 May; 89(5):619-27. PubMed ID: 8758572
[TBL] [Abstract][Full Text] [Related]
8. Impact of molecular genetics in cardiac diseases.
Schwartz K
Herz; 1994 Apr; 19(2):69-74. PubMed ID: 8194834
[TBL] [Abstract][Full Text] [Related]
9. Impact of molecular genetics on clinical cardiology.
Mayosi BM; Watkins H
J R Coll Physicians Lond; 1999; 33(2):124-31. PubMed ID: 10340258
[No Abstract] [Full Text] [Related]
10. AHA assesses the impact of genotyping on diagnosis of genetic cardiac disease. American Heart Association.
Morey SS
Am Fam Physician; 1999 May; 59(10):2915-6, 2918. PubMed ID: 10348078
[No Abstract] [Full Text] [Related]
11. Genetics of cardiovascular disease.
Cymet T
Compr Ther; 2010; 36():18-9. PubMed ID: 21229815
[TBL] [Abstract][Full Text] [Related]
12. [Genetic aspects of the etiology of arrhythmia].
Thierfelder L
Z Kardiol; 2000; 89 Suppl 3():1-5. PubMed ID: 10810779
[TBL] [Abstract][Full Text] [Related]
13. Hypertrophic cardiomyopathy, long QT interval and coronary perforator disease in the Noonan syndrome.
de Gregorio C; Recupero A
J Cardiovasc Med (Hagerstown); 2020 Feb; 21(2):161-163. PubMed ID: 31592851
[No Abstract] [Full Text] [Related]
14. Cardiac Alterations in Patients with Familial Lipodystrophy.
Romano MMD; Chacon PAI; Ramalho FNZ; Foss MC; Schmidt A
Arq Bras Cardiol; 2020 Feb; 114(2):305-312. PubMed ID: 32215503
[TBL] [Abstract][Full Text] [Related]
15. Chronic angiotensin II stimulation in the heart produces an acquired long QT syndrome associated with IK1 potassium current downregulation.
Domenighetti AA; Boixel C; Cefai D; Abriel H; Pedrazzini T
J Mol Cell Cardiol; 2007 Jan; 42(1):63-70. PubMed ID: 17070838
[TBL] [Abstract][Full Text] [Related]
16. New molecular genetic tests in the diagnosis of heart disease.
Lebo MS; Baxter SM
Clin Lab Med; 2014 Mar; 34(1):137-56, vii-viii. PubMed ID: 24507793
[TBL] [Abstract][Full Text] [Related]
17. [Molecular aspects of cardiac hypertrophy and their implications in cardiomyopathies].
Kimura A
Nihon Rinsho; 2000 Jan; 58(1):223-7. PubMed ID: 10885318
[TBL] [Abstract][Full Text] [Related]
18. The ICD for primary prevention in patients with inherited cardiac diseases: indications, use, and outcome: a comparison with secondary prevention.
Olde Nordkamp LR; Wilde AA; Tijssen JG; Knops RE; van Dessel PF; de Groot JR
Circ Arrhythm Electrophysiol; 2013 Feb; 6(1):91-100. PubMed ID: 23275262
[TBL] [Abstract][Full Text] [Related]
19. [Genetics and molecular biology of cardiac hypertrophy].
Rossi G; Cecchi F
G Ital Cardiol; 1995 Dec; 25(12):1643-8. PubMed ID: 8707013
[No Abstract] [Full Text] [Related]
20. [Clinical conditions associated with abnormal QT interval: clinical implications].
Crotti L; Dossena C; Mastantuono E; Dagradi F; Schwartz PJ
G Ital Cardiol (Rome); 2013 Jan; 14(1):55-65. PubMed ID: 23258205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
